Director New Business Development Drug Substance / Boston area
Información general
País
United States
Ciudad
Pennsville, New Jersey
Área funcional
Business Development & Sales
Grupo profesional
Sales and Marketing
Tipo de empleo
Contrato permanente
Número de horas por jornada laboral
tiempo completo
The Siegfried Group is a global life science company with a network of 13 sites in Europe, the USA, and Asia. Siegfried offers contract development and manufacturing of active pharmaceutical ingredients, intermediates, and drug products and has sales more than CHF 1.3 billion Swiss Franks. Siegfried Holding AG employs over 3,800 people and is listed on the SIX Swiss Exchange (SIX: SFZN).
Purpose of Position
This role is strategically important to our company's mission. You will be key to continuing our remarkable growth story by expanding an already robust & diverse client base of innovator companies. This is an opportunity for an individual to step up to a Director role and join a leader in the growing CDMO industry. Expect to grow here!
Trabajar en Siegfried
•Free choice of location paired with remote working
•Flexible working hours
•A generous Employee Stock Purchase Plan
•A generous and stable pension scheme
•Other benefits that tie in with local social security of the location
•We are a growing global company with Swiss roots and 150 years of history
Lo que hacemos en Pennsville
Pennsville is our drug substance manufacturing site for the US market and provides spray drying operations globally.
Main activities
Pilot and commercial manufacturing of drug substances (APIs) and related intermediates
All fully cGMP and SHE compliant
Features
3 GMP pilot suites: 0.1–2 m³ reactors
200m3 commercial capacity: 1–10 m³ reactors
Successful transfer of new products to the commercial scale - Powerful rectification
Spray drying in pilot and commercial scale for both isolation and dispersion technology
Micronization in pilot and commercial
Strategic importance
CMO for innovative drug substances and manufacturer of our opiates portfolio for the US market